Efficacy and Safety of Telmisartan Compared With Losartan

Launched by CHONG KUN DANG PHARMACEUTICAL · May 22, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness and safety of two medications, telmisartan and losartan, for patients with diabetic nephropathy (a kidney condition related to diabetes) and high blood pressure. Researchers want to see which medication works better for managing these conditions. The trial is currently looking for participants aged 19 to 75 who have been diagnosed with Type II diabetes and are already on medication for their diabetes.

If you choose to participate, you will need to sign a consent form and agree to the guidelines set by the study. It’s important to note that this trial is not open to individuals with Type I diabetes, those who are pregnant or breastfeeding, or those who have recently participated in other clinical trials. Participants can expect regular check-ins and monitoring throughout the study to ensure their safety and to gather information about how well the medications work. By joining this trial, you could contribute valuable information that may help improve treatment options for people with similar health issues in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male of Female subjects aged ≥19 or \<75
• • Type II Diabetes Mellitus subjects who have been taken medicine
• • Subjects who have voluntarily decided to participate in this clinical trial and Signed ICF
• Exclusion Criteria:
• • Subjects with Type I Diabetes Mellitus
• • Subjects with Primary hyper-aldosteronism
• • Subjects with a history of drug or alcohol abuse or suspected patient within 1 year as of the time of screening
• • Pregnant women, lactating women, or subjects who do not agree to use appropriate contraception during the clinical trial period
• • Subjects who received other clinical trial drugs within 28 days of screening visit
• • Subjects who are unable to participate in this clinical trial at the discretion of the investigator.

Trial Officials